Xtant Medical (NYSEAMERICAN:XTNT) Issues Quarterly Earnings Results, Beats Expectations By $0.14 EPS

Xtant Medical (NYSEAMERICAN:XTNT) released its quarterly earnings results on Thursday. The medical device company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.14, Fidelity Earnings reports. The company had revenue of $15.72 million during the quarter.

Xtant Medical stock traded down $0.04 on Friday, hitting $2.12. 6,500 shares of the stock traded hands, compared to its average volume of 6,793. Xtant Medical has a 1 year low of $1.61 and a 1 year high of $4.75.

About Xtant Medical

Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.

Further Reading: Equity Income

Earnings History for Xtant Medical (NYSEAMERICAN:XTNT)

Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.